U.S. pharma large copyright scrapped two experimental weight loss drugs final 12 months—a the moment-daily capsule, lotiglipron, on account of elevated liver enzymes and a twice-each day capsule, danuglipron, due to powerful side effects—but CEO Albert Bourla has said the company is decided to “play and get” while in the weight problems Roo